Abstract
Thyroid associated orbitopathy (TAO) is a common diagnosis encountered by ophthalmologists and oculoplastic surgeons. TAO has a varying clinical presentation that can include upper eyelid retraction, restrictive strabismus, proptosis, exposure keratopathy, and optic neuropathy. In this review, we discuss the most recent literature on and the current understanding of the pathophysiology of TAO. We also review available and potential future treatment options for the management of TAO.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 21-33 |
| Number of pages | 13 |
| Journal | Ophthalmology and Therapy |
| Volume | 9 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 1 2020 |
Keywords
- Corticosteroid
- Graves’ orbitopathy
- Rituximab
- Selenium
- Teprotumumab
- Thyroid associated orbitopathy
- Thyroid eye disease
- Tocilizumab
ASJC Scopus subject areas
- Ophthalmology